{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:43:57Z","timestamp":1788669837490,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":3420,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/jth.12317","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T10:04:35Z","timestamp":1371117875000},"page":"1449-1453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis"],"prefix":"10.1016","volume":"11","author":[{"given":"M.","family":"Escobar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12317_bb0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/mp.55.2.127","article-title":"Haemophilia A and haemophilia B: molecular insights","volume":"55","author":"Bowen","year":"2002","journal-title":"Mol Pathol"},{"key":"10.1111\/jth.12317_bb0015","unstructured":"World Federation of Hemophilia. Guidelines for the management of hemophilia. http:\/\/www.wfh.org\/2\/docs\/Publications\/Diagnosis_and_Treatment\/Guidelines_Mng_Hemophilia.pdf. Accessed 22 August 2011."},{"key":"10.1111\/jth.12317_bb0020","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","article-title":"Haemophilias A and B","volume":"361","author":"Bolton\u2010Maggs","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/jth.12317_bb0025","series-title":"Williams Hematology","article-title":"Hemophilia A and Hemophilia B","author":"Roberts","year":"2010"},{"key":"10.1111\/jth.12317_bb0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/blood-2009-01-195313","article-title":"Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders","volume":"114","author":"Tagariello","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12317_bb0035","unstructured":"Haemophilia A \u2010 summary of unique mutations reported. Available at: http:\/\/hadb.org.uk\/WebPages\/PublicFiles\/MutationSummary.htm. Accessed 7 November 2012."},{"key":"10.1111\/jth.12317_bb0040","unstructured":"Rallapalli PM, Kemball\u2010Cook G, Tuddenham EG, Gomez K, Perkins SJ. Factor IX mutation database. Available at: http:\/\/www.factorix.org\/. Accessed 7 November 2012."},{"key":"10.1111\/jth.12317_bb0045","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1538-7836.2010.03767.x","article-title":"Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile","volume":"8","author":"Santagostino","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12317_bb0050","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-0037-1615015","article-title":"Small deletion\/insertion mutations within poly\u2010A runs of the factor VIII gene mitigate the severe haemophilia A phenotype","volume":"79","author":"Oldenburg","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12317_bb0055","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood.V91.2.538","article-title":"The molecular basis for cross\u2010reacting material\u2010positive hemophilia A due to missense mutations within the A2\u2010domain of factor VIII","volume":"91","author":"Amano","year":"1998","journal-title":"Blood"},{"key":"10.1111\/jth.12317_bb0060","series-title":"Genetics of Hemophilia A and B. An introduction for clinicians","author":"Kasper","year":"2007"},{"key":"10.1111\/jth.12317_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0887-7963(87)70018-2","article-title":"The molecular genetics of hemophilia B","volume":"1","author":"Geddes","year":"1987","journal-title":"Transfus Med Rev"},{"key":"10.1111\/jth.12317_bb0070","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJM198204013061306","article-title":"Hemophilia B Leyden: a sex\u2010linked hereditary disorder that improves after puberty","volume":"306","author":"Briet","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12317_bb0075","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1073\/pnas.89.14.6300","article-title":"Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden","volume":"89","author":"Reijnen","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.12317_bb0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2125.2010.03899.x","article-title":"Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice","volume":"72","author":"Franchini","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jth.12317_bb0085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.2007.06657.x","article-title":"Inhibitor development in haemophilia B: an orphan disease in need of attention","volume":"138","author":"Di Michele","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12317_bb0090","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1365-2516.2011.02506.x","article-title":"Comparing bleed frequency and factor concentrate use between haemophilia A and B patients","volume":"17","author":"Nagel","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12317_bb0095","first-page":"P0807","article-title":"Comparing bleed frequency and factor concentrate use between haemophilia A and haemophilia B","volume":"3","author":"Pai","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12317_bb0100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1365-2516.2003.00757.x","article-title":"The overall effectiveness of prophylaxis in severe haemophilia","volume":"9","author":"Panicker","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12317_bb0105","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2006-10-050435","article-title":"Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV","volume":"110","author":"Darby","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.12317_bb0110","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1538-7836.2008.03001.x","article-title":"Validation of a composite score for clinical severity of hemophilia","volume":"6","author":"Schulman","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1111\/jth.12317_bb0115","first-page":"S26","article-title":"Haemophilia A and haemophilia B. Are there relevant clinical differences?","volume":"30","author":"Klamroth","year":"2010","journal-title":"Hamostaseologie"},{"key":"10.1111\/jth.12317_bb0120","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/hae.12073","article-title":"Prevalence of clinical hip abnormalities in haemophilia A and B: an analysis of the UDC database","volume":"19","author":"Kelly","year":"2013","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12317_bb0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2516.2010.02391.x","article-title":"Difference in TFPI levels between haemophilia A and B patients","volume":"17","author":"Tardy\u2010Poncet","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12317_bb0130","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1073\/pnas.1119858109","article-title":"Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia","volume":"109","author":"Maroney","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.12317_bb0135","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2008-06-162453","article-title":"Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency","volume":"112","author":"Duckers","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12317_bb0140","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1365-2516.2009.02080.x","article-title":"Polymorphism in factor VII gene modifies phenotype of severe haemophilia","volume":"15","author":"Jayandharan","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12317_bb0145","first-page":"592","article-title":"Genetic modulation of coagulation factor VII plasma levels: contribution of different polymorphisms and gender\u2010related effects","volume":"80","author":"Di Castelnuovo","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12317_bb0150","first-page":"279","article-title":"The prothrombin 20210A allele influences clinical manifestations of hemophilia A in patients with intron 22 inversion and without inhibitors","volume":"87","author":"Tizzano","year":"2002","journal-title":"Haematologica"},{"key":"10.1111\/jth.12317_bb0155","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood.V88.4.1183.bloodjournal8841183","article-title":"Moderation of hemophilia A phenotype by the factor V R506Q mutation","volume":"88","author":"Nichols","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12317_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2516.1996.tb00011.x","article-title":"Association of severe haemophilia A and factor V Leiden: report of three cases","volume":"2","author":"Arruda","year":"1996","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12317_bb0165","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0037-1613824","article-title":"Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A","volume":"83","author":"Lee","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12317_bb0170","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/1076029608319946","article-title":"The impact of prothrombotic mutations on factor consumption in adult patients with severe hemophilia","volume":"15","author":"Ar","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/jth.12317_bb0175","article-title":"Effect of prothrombotic mutations on factor consumption in children with hemophilia","author":"Tuten","year":"2012","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/jth.12317_bb0180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2009.11.003","article-title":"Factor V Leiden and hemophilia","volume":"125","author":"Franchini","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12317_bb0185","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1365-2516.2008.01810.x","article-title":"The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey","volume":"14","author":"Biss","year":"2008","journal-title":"Haemophilia"},{"issue":"Suppl. 6","key":"10.1111\/jth.12317_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2516.2010.02301.x","article-title":"Prophylaxis in haemophilia B patients: unresolved issues and pharmacoeconomic implications","volume":"16","author":"Santagostino","year":"2010","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12317","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12317","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622136482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622136482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12317\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:03:31Z","timestamp":1761534211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622136482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1538783622136482"],"URL":"https:\/\/doi.org\/10.1111\/jth.12317","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}